Comparing two bladder medications for overactive bladder
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two medicines, solifenacin and mirabegron, to see which one works better and has fewer side effects for people with overactive bladder. It aims to find the best treatment option to reduce urgency and frequent urination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with a diagnosis of overactive bladder (sudden urges to urinate, frequent urination).
- You have never taken medication for overactive bladder before.
- You can fill out a questionnaire about your symptoms and keep a bladder diary.
- You are willing to take one of the two study medicines for the duration of the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
This trial looks at whether simple blood tests can predict how well women with overactive bladder will respond to a medicine called mirabegron. If you have had symptoms for at least 3 months and your doctor plans to start mirabegron, this study may help tailor your treatment.
This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.
This study compares two non-drug treatments for overactive bladder: a nerve stimulation therapy (peroneal neuromodulation) and pelvic floor muscle exercises. It aims to see which is more effective in reducing urgency and frequent urination.
Hear when a new Overactive Bladder (OAB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.